Edge Therapeutics, IncEDGE was a big mover last session, as the company saw its shares rise over 19% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $7.55 to $8.89 in the past one-month time frame.
In the past one month, the company has seen one positive revision and its Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday's jump can turn into more strength down the road.
Edge Therapeutics has Zacks Rank #2 (Buy), while its Earnings ESP is 0.00%.
Another favorably ranked biomedical stock is HESKA CORP HSKA , sporting a Zacks Rank #1 (Strong Buy).
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.